CryoLife’s BioGlue(R) Surgical Adhesive Receives European Approval For Use In Browlift Cosmetic And Reconstructive Plastic Surgery

CryoLife, Inc. (NYSE: CRY), and BioForm Medical, Inc. (Nasdaq: BFRM) announced that they have received a CE Mark for the use of CryoLife’s BioGlue Surgical Adhesive for periosteal fixation following endoscopic browplasty or brow lift, a reconstructive plastic surgery procedure. The CE Mark approval allows the product to be marketed in the European Community (EU).

More: continued here

Filed under: Cosmetic Medicine on June 11th, 2008